Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Massachusetts Doctor Cured of Ebola Returning to Liberia

By R&D Editors | December 16, 2014

Dr. Rick Sacra, an American doctor who contracted the Ebola virus in Africa tells members of the media he intends to return to Africa in January at the Massachusetts Statehouse in Boston Tuesday, Dec. 16, 2014. Sacra took part in an event where Massachusetts Gov. Deval Patrick announced a $1 million grant to a partnership of local life sciences companies, nonprofits and academic institutions lead by Diagnostics For All, a nonprofit organization, attempting to speed up the launch of an rapid Ebola detection tool already in development. (AP Photo/Stephan Savoia)

A Massachusetts doctor cured of Ebola said Tuesday that he’s returning to Liberia, the West African country where he contracted the virus, in January to resume working at a medical mission.

Dr. Richard Sacra said that he plans to spend four weeks at ELWA Hospital, a clinic outside Monrovia where he had contracted the deadly virus in August.

Sacra spent weeks in treatment at an Omaha, Nebraska, hospital before returning home on Sept. 25. The University of Massachusetts Medical School faculty member has worked in medical missions in Liberia for more than 20 years, including the North Carolina-based charity SIM, which founded ELWA Hospital.

Sacra, who was one of at least 10 people so far treated for Ebola in the U.S., said he “feels great” and that doctors have said he’s now effectively immune to Ebola, which has no vaccine.

“I’m not hearing a lot of pushback from home,” Sacra said. “I’ve been working there for years, and my risk at this point is no different than it was before because I’m immune to Ebola.”

Sacra has said he’s not sure exactly when he became infected. He had been caring for pregnant women not suspected to have Ebola and delivering babies, including performing several cesarean sections.

He said ELWA Hospital, which stands for Eternal Love Winning Africa, has changed its protocols following his illness.

“Even if we haven’t suspected Ebola in that patient, we’re now wearing full protective gear at our facility for deliveries,” he said. “When we’re doing surgeries, we’re now getting bleached down at the end, which we weren’t doing before.”

Sacra, who expressed a desire to return to Liberia almost as soon as he recovered, made the comments following a Tuesday news conference at the Statehouse announcing a $1 million state grant to help develop a faster, more accurate test for diagnosing Ebola.

Gov. Deval Patrick said the investment, made through the Massachusetts Life Sciences Center, a quasi-public state agency, will assure the state and its major research institutions will play a central role in saving many lives from Ebola, which has killed 6,400 people during the most recent outbreak in West Africa.

Source: Associated Press

Related Articles Read More >

Thermo Fisher’s new Orbitrap Excedion Pro targets complex biotherapeutics for drug development
FDA’s new ‘Elsa’ AI set to expedite clinical protocol reviews
Waters touts six-fold robustness with new Xevo TQ Absolute XR
Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE